Mission Statement

Cellular Engineering Technologies (CET) is a biotechnology company specializing in stem cell research, cancer biology and high throughput sensor fabrication. Our goal is to develop novel technologies to expedite drug discovery and screening processes. In addition, CET conducts translational research on non-embryonic stem cells with the ultimate goal of treating human disease. CET’s business focuses on three major themes: (1) stem cell research, (2) cancer biology, and (3) bioassay development and drug discovery using specialized high throughput sensors.

Our Business

Our business is designed to reduce the time and cost of preclinical research and development by applying cellular and tissue engineering technologies to our customer’s research needs. We are a leading provider of non-embryonic stem and ancillary cells, cancer tissue and cell lines, and immunological cells from human donors. In addition, CET is a research and development company that combines life science expertise in cell biology and clinical medicine with disciplines in biomedical engineering. We employ life science and engineering professionals to conduct custom preclinical cell-based assay development, drug screening, drug discovery and clinical research.